BioCardia, Inc. Restricted Cash and Investments, Current
BioCardia, Inc. (BCDA) had Restricted Cash and Investments, Current of $0 as of 2012-12-31, per its 10-K filed 2013-03-22.
Discontinued › Balance Sheet › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:RestrictedCashAndInvestmentsCurrent · last filed 2013-03-22
- 2012-12-31: Restricted Cash and Investments, Current $0.00.
- 2012-09-30: Restricted Cash and Investments, Current $0.00.
- 2012-06-30: Restricted Cash and Investments, Current $0.00.
- 2012-03-31: Restricted Cash and Investments, Current $900.00K.
| Period end | Restricted Cash and Investments, Current |
|---|---|
| 2012-12-31 | $0.00 10-K · filed 2013-03-22 |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-08 |
| 2012-06-30 | $0.00 10-Q · filed 2012-08-10 |
| 2012-03-31 | $900.00K 10-Q · filed 2012-05-15 |
| 2011-12-31 | $900.00K 10-K · filed 2013-03-22 |
| 2011-09-30 | $1.22M 10-Q · filed 2011-11-15 |
| 2011-06-30 | $1.46M 10-Q/A · filed 2011-11-17 |
| 2010-12-31 | $0.00 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |